Antitumor activity of Noscapine in combination with Doxorubicin in triple negative breast cancer.
about
The Noscapine Chronicle: A Pharmaco-Historic Biography of the Opiate Alkaloid Family and its Clinical ApplicationsPiperlongumine for Enhancing Oral Bioavailability and Cytotoxicity of Docetaxel in Triple-Negative Breast CancerNanomiemgel--a novel drug delivery system for topical application--in vitro and in vivo evaluationTopical delivery of anti-TNFα siRNA and capsaicin via novel lipid-polymer hybrid nanoparticles efficiently inhibits skin inflammation in vivo.Phytoagent Deoxyelephantopin and Its Derivative Inhibit Triple Negative Breast Cancer Cell Activity through ROS-Mediated Exosomal Activity and Protein Functions.Enhanced anticancer activity of gemcitabine in combination with noscapine via antiangiogenic and apoptotic pathway against non-small cell lung cancer.Non-addictive opium alkaloids selectively induce apoptosis in cancer cells compared to normal cells.Epithelial transport of noscapine across cell monolayer and influence of absorption enhancers on in vitro permeation and bioavailability: implications for intestinal absorption.Experimental treatment of breast cancer-bearing BALB/c mice by artemisinin and transferrin-loaded magnetic nanoliposomesFormulation, Pharmacokinetic, and Efficacy Studies of Mannosylated Self-Emulsifying Solid Dispersions of Noscapine.Metabolic map and bioactivation of the anti-tumour drug noscapine.Investigation of follicular and non-follicular pathways for polyarginine and oleic acid-modified nanoparticlesCharacterization of inhibition kinetics of (S)-warfarin hydroxylation by noscapine: implications in warfarin therapy.1,1-Bis (3'-indolyl)-1-(p-substitutedphenyl)methane compounds inhibit lung cancer cell and tumor growth in a metastasis model.Apoptosis induction of human endometriotic epithelial and stromal cells by noscapine.Identification and Testing of Novel CARP-1 Functional Mimetic Compounds as Inhibitors of Non-Small Cell Lung and Triple Negative Breast Cancers.Noscapine chemosensitization enhances docetaxel anticancer activity and nanocarrier uptake in triple negative breast cancerCARP-1 functional mimetics are novel inhibitors of drug-resistant triple negative breast cancers.Anti‑proliferative activity of epigallocatechin‑3‑gallate and silibinin on soft tissue sarcoma cells.Peloruside, laulimalide, and noscapine interactions with beta-tubulin.Etoposide and doxorubicin enhance the sensitivity of triple negative breast cancers through modulation of TRAIL-DR5 axis.Enhanced antitumor activity and attenuated cardiotoxicity of Epirubicin combined with Paeonol against breast cancer.Noscapine Increases the Sensitivity of Drug-Resistant Ovarian Cancer Cell Line SKOV3/DDP to Cisplatin by Regulating Cell Cycle and Activating Apoptotic Pathways.Novel insight into triple-negative breast cancers, the emerging role of angiogenesis, and antiangiogenic therapy.BTG2 inhibits the proliferation, invasion, and apoptosis of MDA-MB-231 triple-negative breast cancer cells.The effects of RKIP gene expression on the biological characteristics of human triple-negative breast cancer cells in vitro.Skin permeating nanogel for the cutaneous co-delivery of two anti-inflammatory drugsReversal of drug-resistance by noscapine chemo-sensitization in docetaxel resistant triple negative breast cancer.Cholecalciferol-PEG Conjugate Based Nanomicelles of Doxorubicin for Treatment of Triple-Negative Breast Cancer.Schedule dependent synergy of gemcitabine and doxorubicin: Improvement of in vitro efficacy and lack of in vitro-in vivo correlation.Metabolism profiling of amino-noscapine.Synergistic Anticancer Effect of Paclitaxel and Noscapine on Human Prostate Cancer Cell Lines.Structural investigations into the binding mode of a novel noscapine analogue, 9-(4-vinylphenyl) noscapine, with tubulin by biochemical analyses and molecular dynamic simulations.Nuclear Insulin-Like Growth Factor Binding Protein-3 As a Biomarker in Triple-Negative Breast Cancer Xenograft Tumors: Effect of Targeted Therapy and Comparison With Chemotherapy.
P2860
Q26801133-E26C02F7-5477-4D9A-AE21-9476D9640106Q28383510-D13087ED-2ADE-4F25-9A14-DE49E3302816Q28542908-92CCBE36-BA9F-4D8C-87AF-6EDC2C0492CCQ30432272-E463B516-9FE1-49F8-BEF4-C2A78907062FQ33851617-D5F37EB7-6536-42C6-95C4-E58057CF2544Q34079286-9398D15C-8FB2-49E2-B38A-F2B80C53408FQ35124716-3E5A6B37-CCFA-41A5-9924-B00BBE48950FQ35147276-ED1E3F6F-CE89-4B0A-AF5C-0A78554F9BCCQ35709845-DE9D2D49-E016-496C-9AC8-757F0B8DD6D8Q35891741-A7387CBC-6FEB-476E-9AA8-EDF35A988409Q36419303-6FF1803A-E503-403C-AA04-7CE511405890Q37141351-DF4601BB-FBD6-4C06-A7D6-8BE14AA873D2Q37325594-F39A3D46-D657-4A33-8170-A8BF59C3547FQ37338514-7DAC6721-E22E-46D4-9273-E7BE09A34649Q37366438-49C92C10-525E-4DB1-BC4F-8C4EF35C4E49Q37386051-5F0F6C82-DD80-48F1-9178-16BF346292BFQ37426564-FA0CAB7A-B14F-47CF-A2B4-9243429B85BBQ37687393-69A10E25-0784-4CF7-82A2-0D64300FF5BAQ37707691-B649085D-681C-4D96-901F-965BEB06A340Q38021666-B8934A82-5A8E-4D57-B347-F1379D52FBF8Q38681598-E2A55090-2BBA-4BB3-9DDF-23BAA287F72AQ38737034-BF21E911-08CF-4C7C-A490-DA036D3F6982Q38928436-2E3FC0E9-AC0A-452D-9F67-216CC5644601Q39000232-3FAF9636-B2BD-4038-A44D-FBB5FADBBFB1Q39192269-C67D7558-FCC4-415A-B01A-5FAFB5A0129BQ39388734-FD9A7C69-AB35-4BC1-AA8C-349975A557BAQ39897426-CCA6A921-2BB9-40E0-92CC-3C318B619B0EQ47311101-2D421A4D-061D-4233-9205-E38501D3B5CFQ49743645-D783DCF9-4466-44CC-BE90-02A724BE628BQ53465288-4A63F3AF-F203-4BA7-AABC-96F4E957C633Q53657031-6F0D3F02-DAC1-4330-9DD8-3918A0D34894Q53701201-18DF8C3D-BB71-4F29-A09E-DD027277113FQ54035369-ACBF1EE9-DC1F-4301-9F8A-88218859A757Q54117329-05051CD6-3E59-4DF6-BCC7-9E941EE42491
P2860
Antitumor activity of Noscapine in combination with Doxorubicin in triple negative breast cancer.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Antitumor activity of Noscapin ...... triple negative breast cancer.
@ast
Antitumor activity of Noscapin ...... triple negative breast cancer.
@en
type
label
Antitumor activity of Noscapin ...... triple negative breast cancer.
@ast
Antitumor activity of Noscapin ...... triple negative breast cancer.
@en
prefLabel
Antitumor activity of Noscapin ...... triple negative breast cancer.
@ast
Antitumor activity of Noscapin ...... triple negative breast cancer.
@en
P2093
P2860
P1433
P1476
Antitumor activity of Noscapin ...... triple negative breast cancer.
@en
P2093
Apurva R Patel
Mahavir B Chougule
Mandip Singh
Tanise Jackson
P2860
P304
P356
10.1371/JOURNAL.PONE.0017733
P407
P577
2011-03-15T00:00:00Z